We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should Value Investors Buy Ono Pharmaceutical Co. (OPHLF) Stock?
Read MoreHide Full Article
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company to watch right now is Ono Pharmaceutical Co. (OPHLF - Free Report) . OPHLF is currently holding a Zacks Rank #2 (Buy) and a Value grade of A.
Investors should also recognize that OPHLF has a P/B ratio of 0.9. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. OPHLF's current P/B looks attractive when compared to its industry's average P/B of 1.54. OPHLF's P/B has been as high as 1.33 and as low as 0.80, with a median of 0.97, over the past year.
Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. OPHLF has a P/S ratio of 2.02. This compares to its industry's average P/S of 3.05.
Finally, we should also recognize that OPHLF has a P/CF ratio of 9.59. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 12.44. Over the past 52 weeks, OPHLF's P/CF has been as high as 11.56 and as low as 5.73, with a median of 8.47.
These figures are just a handful of the metrics value investors tend to look at, but they help show that Ono Pharmaceutical Co. is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, OPHLF feels like a great value stock at the moment.
View the Zacks #1 Rank List
Image: Bigstock
Should Value Investors Buy Ono Pharmaceutical Co. (OPHLF) Stock?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company to watch right now is Ono Pharmaceutical Co. (OPHLF - Free Report) . OPHLF is currently holding a Zacks Rank #2 (Buy) and a Value grade of A.
Investors should also recognize that OPHLF has a P/B ratio of 0.9. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. OPHLF's current P/B looks attractive when compared to its industry's average P/B of 1.54. OPHLF's P/B has been as high as 1.33 and as low as 0.80, with a median of 0.97, over the past year.
Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. OPHLF has a P/S ratio of 2.02. This compares to its industry's average P/S of 3.05.
Finally, we should also recognize that OPHLF has a P/CF ratio of 9.59. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 12.44. Over the past 52 weeks, OPHLF's P/CF has been as high as 11.56 and as low as 5.73, with a median of 8.47.
These figures are just a handful of the metrics value investors tend to look at, but they help show that Ono Pharmaceutical Co. is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, OPHLF feels like a great value stock at the moment.